Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1988 Sep 3;297(6648):571–572. doi: 10.1136/bmj.297.6648.571

Oestrogens and cardiovascular disease.

R Beaglehole 1
PMCID: PMC1834506  PMID: 3139216

Full text

PDF
571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam S., Williams V., Vessey M. P. Cardiovascular disease and hormone replacement treatment: a pilot case-control study. Br Med J (Clin Res Ed) 1981 Apr 18;282(6272):1277–1278. doi: 10.1136/bmj.282.6272.1277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A., Rifkind B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. doi: 10.1161/01.cir.75.6.1102. [DOI] [PubMed] [Google Scholar]
  3. Bush T. L., Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev. 1985;7:89–104. [PubMed] [Google Scholar]
  4. Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987 Apr 30;316(18):1105–1110. doi: 10.1056/NEJM198704303161801. [DOI] [PubMed] [Google Scholar]
  5. Henderson B. E., Ross R. K., Paganini-Hill A., Mack T. M. Estrogen use and cardiovascular disease. Am J Obstet Gynecol. 1986 Jun;154(6):1181–1186. doi: 10.1016/0002-9378(86)90696-4. [DOI] [PubMed] [Google Scholar]
  6. Hillner B. E., Hollenberg J. P., Pauker S. G. Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered. Am J Med. 1986 Jun;80(6):1115–1127. doi: 10.1016/0002-9343(86)90674-1. [DOI] [PubMed] [Google Scholar]
  7. Hirvonen E., Mälkönen M., Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med. 1981 Mar 5;304(10):560–563. doi: 10.1056/NEJM198103053041002. [DOI] [PubMed] [Google Scholar]
  8. Petitti D. B., Perlman J. A., Sidney S. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol. 1987 Sep;70(3 Pt 1):289–293. [PubMed] [Google Scholar]
  9. Stadel B. V. Oral contraceptives and cardiovascular disease (first of two parts). N Engl J Med. 1981 Sep 10;305(11):612–618. doi: 10.1056/NEJM198109103051104. [DOI] [PubMed] [Google Scholar]
  10. Stadel B. V. Oral contraceptives and cardiovascular disease (second of two parts). N Engl J Med. 1981 Sep 17;305(12):672–677. doi: 10.1056/NEJM198109173051205. [DOI] [PubMed] [Google Scholar]
  11. Stampfer M. J., Willett W. C., Colditz G. A., Rosner B., Speizer F. E., Hennekens C. H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985 Oct 24;313(17):1044–1049. doi: 10.1056/NEJM198510243131703. [DOI] [PubMed] [Google Scholar]
  12. Wilson P. W., Garrison R. J., Castelli W. P. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med. 1985 Oct 24;313(17):1038–1043. doi: 10.1056/NEJM198510243131702. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES